Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06155565
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-04
First Post:
2023-11-24
Brief Title:
Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research
Sponsor:
Power Life Sciences Inc
Organization:
Power Life Sciences Inc
Study Overview
Official Title:
Investigating Patterns in Enrollment and Engagement Among Individuals Coping With Anxiety Disorder
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Clinical trials specifically focused on anxiety disorder are crucial in assessing the safety and efficacy of new treatments These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies providing compelling evidence to support wider implementation
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None